tividenofusp alfa-eknm (Avlayah)
Jump to navigation
Jump to search
Indications
- treatment of Hunter syndrome
Dosage
- once a week infusion
Mechanism of action
- increases iduronate 2-sulfatase activity
More general terms
References
- ↑ Sneha S K, Kunal Das US FDA approves Denali's genetic disorder therapy for children. Reuters. March 25, 2026 https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-denalis-genetic-disorder-therapy-2026-03-25/